Skip to main content
CNTB logo
CNTB
(NASDAQ)
Connect Biopharma Holdings Limited
$2.99-- (--)
Loading... - Market loading

Connect Biopharma Holdings (CNTB) Stock Price & Financial Analysis

Connect Biopharma Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.72 - $3.02
52-Week High$3.82
52-Week Low$0.51
Open$2.90
Volume852.38K
Average Volume (3M)852.38K
Market Cap166.59M
Shares Outstanding55.72M
Price to Sales (P/S)56.67
Price to Book (P/B)2.74
EV/EBITDA-1.76
Revenue (TTM)2.67M
Net Income (TTM)-63.59M
Free Cash Flow (TTM)-56.26M
EPS (TTM)$-1.14
Profit Margin-2377.95%
Operating Margin-2522.51%
Return on Equity (ROE)-114.84%
Debt to Equity0.01
50-Day MA$2.69
200-Day MA$2.11
52-Week Change375.36%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Connect Biopharma Holdings

What is the current stock price for CNTB?

As of the latest trading session, CNTB stock trades at $2.99. The 52-week range is $0.51–$3.82, with a day range of $2.72–$3.02.

What is the P/E ratio for CNTB?

The P/E ratio (Price-to-Earnings) for CNTB is shown in the Key Statistics section. This valuation metric helps compare Connect Biopharma Holdings Limited to industry peers.

Does CNTB pay dividends?

Connect Biopharma Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CNTB?

Based on 1 analyst, the consensus for CNTB is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CNTB?

Connect Biopharma Holdings's market capitalization is $166.6M, classifying it as a micro-cap company. Connect Biopharma Holdings operates in the Healthcare sector within the Biotechnology industry.